Pierre D. Delmas
Inserm Research Unit 403 and Claude Bernard University of Lyon
France
Name/email consistency: high
- Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis. Delmas, P.D. Bone (2002)
- The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis. Delmas, P.D., Calvo, G., Boers, M., Abadie, E., Avouac, B., Kahan, A., Kaufman, J.M., Laslop, A., Lekkerkerker, J.F., Nilsson, P., Van Zwieten-Boot, B., Kreutz, G., Reginster, J.Y. Osteoporos. Int (2002)
- Treatment of postmenopausal osteoporosis. Delmas, P.D. Lancet (2002)
- Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. Delmas, P.D., Ensrud, K.E., Adachi, J.D., Harper, K.D., Sarkar, S., Gennari, C., Reginster, J.Y., Pols, H.A., Recker, R.R., Harris, S.T., Wu, W., Genant, H.K., Black, D.M., Eastell, R. J. Clin. Endocrinol. Metab. (2002)
- Osteoporosis in patients with organ transplants: a neglected problem. Delmas, P.D. Lancet (2001)
- Monitoring individual response to hormone replacement therapy with bone markers. Delmas, P.D., Hardy, P., Garnero, P., Dain, M. Bone (2000)
- Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Delmas, P.D. Osteoporos. Int (2000)